Yes / Background: Understanding and countering the well-established negative health consequences of spaceflight remains a primary challenge preventing safe deep space exploration. Targeted/personalized therapeutics are at the forefront of space medicine strategies, and cross-species molecular signatures now define the 'typical' spaceflight response. However, a lack of direct genotype-phenotype associations currently limits the robustness and, therefore, the therapeutic utility of putative mechanisms underpinning pathological changes in flight. Methods: We employed the worm Caenorhabditis elegans as a validated model of space biology, combined with 'NemaFlex-S' microfluidic devices for assessing animal strength production as one of the most reproducible physiological responses to spaceflight. Wild-type and dys-1 (BZ33) strains (a Duchenne muscular dystrophy (DMD) model for comparing predisposed muscle weak animals) were cultured on the International Space Station in chemically defined media before loading second-generation gravid adults into NemaFlex-S devices to assess individual animal strength. These same cultures were then frozen on orbit before returning to Earth for next-generation sequencing transcriptomic analysis. Results: Neuromuscular strength was lower in flight versus ground controls (16.6% decline, p

No description available.

A sépsis e o choque séptico representam uma síndrome complexa de intensa resposta inflamatória sistêmica, com múltiplas anormalidades fisiológicas e imunológicas, comumente causadas por infecção bacteriana. A principal conseqüência dessa resposta é o comprometimento de muitos órgãos e tecidos. A disfunção cardíaca, decorrente de um prejuízo na contratilidade miocárdica, tem sido reconhecida como um fator importante que contribui para os altos índices de mortalidade observados na sépsis. Dados recentes do nosso laboratório indicam que alterações estruturais no miocárdio podem ser responsáveis pela disfunção cardíaca observada na sépsis. Considerando que a maquinaria contrátil interna das miofibras deve permanecer intimamente conectada com a membrana e a matriz extracelular, o presente estudo foi proposto para avaliar alterações nas comunicações intercelulares e acoplagem mecânica entre os cardiomiócitos vizinhos e avaliar a expressão de proteínas do arcabouço celular e da matriz extracelular (especificamente a laminina-?2) durante a sépsis grave. Nossos resultados mostraram que há uma diminuição na expressão das proteínas envolvidas na formação das gap junctions (conexina43) e junções aderentes (N-caderina), o que resultaria na perda da integridade estrutural dos discos intercalares, alterando o acoplamento mecânico e eletro-químico entre os cardiomiócitos vizinhos. Além disso, demonstramos que há redução na expressão de distrofina e das proteínas que constituem o complexo de glicoproteínas associadas a distrofina (CGD) durante a sépsis experimental. A redução ou perda da expressão de distrofina é o evento primário que ocorre seguido pela degeneração miofilamentar, caracterizada pela lise dos filamentos de actina e miosina. A diminuição na expressão das glicoproteínas associadas à distrofina: -distroglicana e laminina foram considerados eventos secundários. Os resultados sugerem que durante a sépsis induzida por ligação e perfuração do ceco (CLP), há perda de proteínas importantes envolvidas tanto no remodelamento do disco intercalar quanto na expressão de glicoproteínas envolvidas na ligação mecânica entre o citoesqueleto intracelular e a matriz extracelular. Embora estudos funcionais sejam necessários para determinar o efeito direto dessas alterações sobre o miocárdio podemos sugerir que as alterações estruturais são parcialmente responsáveis pela depressão miocárdica observada na sépsis. / Sepsis and septic shock represent a complex syndrome of systemic inflammatory response, with multiple physiological and immunological abnormalities, commonly caused by bacterial infection. The most important consequence of the response is the involvement of many organs and tissues. Cardiac dysfunction, caused by impairment in myocardial contractility, has been recognized as an important factor that contributes to the high mortality observed in sepsis. Evidence from our laboratory indicates that myocardial structural changes could be responsible for sepsis-induced myocardial dysfunction. Taking into account that the contractile machinery inside the myofibers must remain intimately connected with the membrane and extracellular matrix, the present investigation sought to evaluate changes in intercellular communications and mechanical coupling between the neighbor cardiomyocytes and the expression of the cell scaffold protein and extracellular matrix (specifically merosin laminin-2 chain) during the severe sepsis. Our results showed a decrease in the expression of proteins involved in formation of gap junctions (connexin-43) and adherens junctions (N-cadherin). These alterations may result in the loss of intercalated disc structural integrity, changing the mechanical and electrical-chemical coupling between neighboring cardiomyocytes. Additionally, we demonstrated the decrease of dystrophin and dystrophin-glycoprotein complex (DGC) components resulting from severe septic injury. The reduction or loss of dystrophin is the primary event that occurs followed by miofilamentar degeneration characterized by actin and myosin lysis. The decrease of glycoproteins associated with dystrophin: -dystroglican and laminin were considered secondary events. The results suggest that during experimental severe sepsis induced by cecal ligation and puncture (CLP), there is loss of important proteins involved in both the remodeling of the intercalated disc and the glycoproteins expression implicated in the mechanical link between the intracellular cytoskeleton and extracellular matrix. Although the functional studies are needed to determine the direct effect of these alterations on myocardium, we can suggest that myocardial structural changes may be partly responsible for sepsis-induced cardiac depression.

A sépsis e o choque séptico representam uma síndrome complexa de intensa resposta inflamatória sistêmica, com múltiplas anormalidades fisiológicas e imunológicas, comumente causadas por infecção bacteriana. A principal conseqüência dessa resposta é o comprometimento de muitos órgãos e tecidos. A disfunção cardíaca, decorrente de um prejuízo na contratilidade miocárdica, tem sido reconhecida como um fator importante que contribui para os altos índices de mortalidade observados na sépsis. Dados recentes do nosso laboratório indicam que alterações estruturais no miocárdio podem ser responsáveis pela disfunção cardíaca observada na sépsis. Considerando que a maquinaria contrátil interna das miofibras deve permanecer intimamente conectada com a membrana e a matriz extracelular, o presente estudo foi proposto para avaliar alterações nas comunicações intercelulares e acoplagem mecânica entre os cardiomiócitos vizinhos e avaliar a expressão de proteínas do arcabouço celular e da matriz extracelular (especificamente a laminina-?2) durante a sépsis grave. Nossos resultados mostraram que há uma diminuição na expressão das proteínas envolvidas na formação das gap junctions (conexina43) e junções aderentes (N-caderina), o que resultaria na perda da integridade estrutural dos discos intercalares, alterando o acoplamento mecânico e eletro-químico entre os cardiomiócitos vizinhos. Além disso, demonstramos que há redução na expressão de distrofina e das proteínas que constituem o complexo de glicoproteínas associadas a distrofina (CGD) durante a sépsis experimental. A redução ou perda da expressão de distrofina é o evento primário que ocorre seguido pela degeneração miofilamentar, caracterizada pela lise dos filamentos de actina e miosina. A diminuição na expressão das glicoproteínas associadas à distrofina: -distroglicana e laminina foram considerados eventos secundários. Os resultados sugerem que durante a sépsis induzida por ligação e perfuração do ceco (CLP), há perda de proteínas importantes envolvidas tanto no remodelamento do disco intercalar quanto na expressão de glicoproteínas envolvidas na ligação mecânica entre o citoesqueleto intracelular e a matriz extracelular. Embora estudos funcionais sejam necessários para determinar o efeito direto dessas alterações sobre o miocárdio podemos sugerir que as alterações estruturais são parcialmente responsáveis pela depressão miocárdica observada na sépsis. / Sepsis and septic shock represent a complex syndrome of systemic inflammatory response, with multiple physiological and immunological abnormalities, commonly caused by bacterial infection. The most important consequence of the response is the involvement of many organs and tissues. Cardiac dysfunction, caused by impairment in myocardial contractility, has been recognized as an important factor that contributes to the high mortality observed in sepsis. Evidence from our laboratory indicates that myocardial structural changes could be responsible for sepsis-induced myocardial dysfunction. Taking into account that the contractile machinery inside the myofibers must remain intimately connected with the membrane and extracellular matrix, the present investigation sought to evaluate changes in intercellular communications and mechanical coupling between the neighbor cardiomyocytes and the expression of the cell scaffold protein and extracellular matrix (specifically merosin laminin-2 chain) during the severe sepsis. Our results showed a decrease in the expression of proteins involved in formation of gap junctions (connexin-43) and adherens junctions (N-cadherin). These alterations may result in the loss of intercalated disc structural integrity, changing the mechanical and electrical-chemical coupling between neighboring cardiomyocytes. Additionally, we demonstrated the decrease of dystrophin and dystrophin-glycoprotein complex (DGC) components resulting from severe septic injury. The reduction or loss of dystrophin is the primary event that occurs followed by miofilamentar degeneration characterized by actin and myosin lysis. The decrease of glycoproteins associated with dystrophin: -dystroglican and laminin were considered secondary events. The results suggest that during experimental severe sepsis induced by cecal ligation and puncture (CLP), there is loss of important proteins involved in both the remodeling of the intercalated disc and the glycoproteins expression implicated in the mechanical link between the intracellular cytoskeleton and extracellular matrix. Although the functional studies are needed to determine the direct effect of these alterations on myocardium, we can suggest that myocardial structural changes may be partly responsible for sepsis-induced cardiac depression.

No description available.

La dystrophine est une protéine filamenteuse qui contribue à la structuration des cellules musculaires en créant un lien entre le cytosquelette et le sarcolemme. Avec l’actine du cytosquelette et les lipides membranaires, la dystrophine représente l’un des éléments d’un complexe macromoléculaire, localisé sous la membrane plasmique, dont le rôle est la prévention des dommages qui pourraient être induits à force de contractions-relâchements répétés. De tels dommages, notamment des ruptures du sarcolemme, sont observés chez des personnes atteintes de myopathies de Duchenne (DMD) et de Becker (BMD), des maladies causées par des mutations qui altèrent l’expression ou la fonction de la dystrophine. Ces myopathies sont actuellement incurables et une connaissance approfondie de la relation structure-fonction de la dystrophine et de ses interactions avec ses partenaires s’avère absolument nécessaire à la mise au point de nouvelles stratégies de thérapies géniques. Cette protéine se compose de quatre domaines fonctionnels, dont un domaine central filamentaire, constitué de 24 répétitions successives d’un même motif structural, un faisceau de trois hélices alpha ou « coiled-coil ». Or, il a été récemment montré que la structure de ce domaine central n’est pas strictement linéaire et que certaines régions inter-répétitions (linker) forment des coudes, délimitant ainsi des sous-domaines d’interaction spécifiques. Cette thèse a pour objectif de comprendre l’origine de cette diversité de conformations inter-répétition dans un domaine structuralement homogène, et d’explorer comment elle permet à certaines régions de se différencier afin d’interagir avec l’actine et/ou les lipides membranaires. / Dystrophin is a filamentous protein involved in muscular cells structure which links the cytoskeleton to the sarcolemma. Together with cytoskeletal actin and membrane lipids, dystrophin is a part of a macromolecular complex, located under the sarcolemma, which prevents damages induced during repeated muscle contractions and relaxations. Such damages, including sarcolemma disruption, are found in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), diseases caused by mutations altering dystrophin expression or function. There is currently no treatment to cure these myopathies, and a deep understanding of the structure-function of the dystrophin and its interactions with its partners is necessary to the development of gene therapy strategies. Structuraly, this protein is composed of four functionnal domains, including a long filamentous central domain, composed of 24 successive coiled-coil repeats. It was recently showed that the central domain is not rod shaped and some inter-repeats regions (linker) are kinked, delimiting specific interaction sub-domains. This thesis aims to bring knowledge about the basis of the conformationnal diversity of linkers in a structuraly homogenous domain in human dystrophin. We explore how dystrophin delimits some regions that interact with f-actin and/or membrane lipids.

Duchenne Muscular Dystrophy (DMD) is a fatal condition occurring in approximately 1 in 3500 male births and is due to the lack of a protein called dystrophin. Initially DMD was considered a skeletal myopathy, but the pathology and consequences of cardiomyopathy are being increasingly recognised. Fibrosis, resulting from continual cycles of degeneration of the muscle tissues followed by inadequate regeneration of the muscles, is progressive in both cardiac and skeletal dystrophic muscle. In the heart fibrosis interferes with contractility and rhythm whereas it affects contractile function and causes contractures in skeletal muscles. This study utilised the mdx mouse which exhibits a pathological loss of muscle fibres and fibrosis characteristic of DMD, to examine a range of mechanisms that can influence muscle function and fibrosis. Ageing and workload both appear to contribute to the development of dystrophic features in cardiac and skeletal muscle of the mdx mouse. Therefore the effect of eccentric exercise on cardiac and skeletal muscle was examined in older mdx mice. Mice ran in 30 minute sessions for five months, 5 days per week. Downhill treadmill running did not exacerbate the contractile function or fibrosis of the mdx heart or the EDL, SOL or diaphragm muscles suggesting that cytokines influence function and fibrosis to a greater extent than workload alone. The role of the cytokine TGF-beta was examined by treating mdx mice with the TGF-beta antagonist pirfenidone at 0.4, 0.8 or 1.2 per cent in drinking water for six months. Pirfenidone improved cardiac contractility (P<0.01) and coronary flow (P<0.05), to levels comparable to control mice, despite no reduction in cardiac fibrosis. Pirfenidone did not reduce fibrosis or improve function in skeletal muscle. A deficiency of neuronal nitric oxide synthase (nNOS) in DMD and mdx mice causes a lowered production of nitric oxide indicating that the substrate of nNOS, l-arginine, may be beneficial to cardiac and skeletal muscle function in mdx mice. Oral l-arginine (5 mg/g bw) improved cardiac contractility, coronary flow and reduced cardiac fibrosis (P<0.05) without improving skeletal muscle function or fibrosis. In contrast, 10 mg/g bw l-arginine improved cardiac function and coronary flow (P<0.01), despite also elevating cardiac collagen. This increment in collagen was prevented by co-administration of prednisone. The experiments described in this dissertation reveal for the first time that pharmacological treatments in mdx mice can improve cardiac structure and function. Further elucidation of the optimum time and doses of such treatments may result in future pharmacological treatments to improve cardiac function and fibrosis in DMD.

Duchenne Muscular Dystrophy (DMD) is an x-linked neuromuscular disease that is caused by an absence of dystrophin protein, rendering skeletal muscle more susceptible to contraction-induced damage. One therapeutic strategy focuses on increasing the expression of endogenous utrophin A, a dystrophin homologue. Interestingly, slow muscle is more resistant to the dystrophic pathology and has increased utrophin A expression (Webster 1998; Gramolini 2001b). These observations led researchers to explore the therapeutic potential of stimulating the slow, oxidative myogenic program (SOMP) in the mdx context. Beneficial adaptations were seen with pharmacological activation of PPARδ and AMPK. We treated mdx mice with resveratrol (~100mg/kg/day), a putative SIRT1 activator, for 6-7 weeks and evaluated the activity of phenotypic modifiers that are known to influence the SOMP. SIRT1 activity and protein levels increased significantly, as well as downstream PGC-1α activity. There was evidence of a fibre type conversion as the treated mice had a higher proportion of the slow myosin heavy chain isoforms in both the EDL and Soleus skeletal muscles. Utrophin A protein levels showed modest, but consistent increases with resveratrol treatment. Finally, histological analysis revealed improvements in central nucleation and fibre size variability. These findings were promising, but raised the question of whether modifying the treatment regimen may result in greater therapeutic benefits. Surprisingly, we discovered that an elevated dose of 500mg/kg/day was ineffective in its promotion of the SOMP. SIRT1 was not activated and there was no change in utrophin A levels with resveratrol treatment. Taken together, this study demonstrates that resveratrol has the ability to promote the SOMP through SIRT1 and PGC-1α activation. It also highlights the importance of selecting an appropriate dose of resveratrol to maximize its effectiveness.

Duchenne Muscular Dystrophy (DMD) is an X-linked recessive genetic disease, caused by a frame-shift mutation in the dystrophin gene. Current gene therapies for DMD target dystrophin transcripts in existing skeletal and cardiac muscle, rather than adipose and fibrotic tissues. These approaches may be unable to repair muscle functionality in DMD patients who have already undergone extensive muscle damage and wasting. Thus, successful DMD therapies must consider the underlying genetic cause and pathology. Inhibition of the gene myostatin, a negative regulator of muscle growth, has been shown to ameliorate muscle loss. Here, the CRISPR-Cas9 gene-editing platform is proposed to restore dystrophin expression and inhibit myostatin as a novel gene therapy in DMD patient derived induced pluripotent stem cells. Successful CRISPR-Cas9 mediated gene editing would be determined using PCR amplification, western blot analysis, immunofluorescence staining, and off target sequence analysis in differentiated skeletal muscle cells.

Orientador: Humberto Santo Neto / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-23T08:31:35Z (GMT). No. of bitstreams: 1 Perez_PaulaSpanopoulos_M.pdf: 4055081 bytes, checksum: 1297b13fc85bb6918c3785c93466dff5 (MD5) Previous issue date: 2013 / Resumo: O resumo poderá ser visualizado no texto completo da tese digital / Abstract: The abstract is available with the full electronic document / Mestrado / Biologia Celular / Mestra em Biologia Celular e Estrutural